Delivery Order SPE2DB22D2005-SPE2DB24FJGG3

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $11K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,814.68 firm-fixed-price delivery order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $15,247.84 firm fixed-price delivery order is for the pharmaceutical product Trulicity 3 mg/0.5 ml pen, which is used to treat diabetes. The contract has an ultimate completion date of December 8, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,234.71, is a delivery order for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen with a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,708.40 firm fixed-price delivery order is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen with a completion date of September 21, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,068.75 Firm Fixed Price Delivery Order is for the pharmaceutical product Trulicity 4.5 mg/0.5 ml Pen 0.5 ml, with a period of performance through September 19, 2023. Amerisourcebergen, as a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,434.10 firm-fixed-price delivery order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen, with a completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order valued at $6,966.72 for the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5 ml. The contract has a period of performance through January 3, 2024 and is a firm fixed price contract type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,955.80 for the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 22, 2024. The contract is a firm fixed-price delivery order without any set-aside designations, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Trulicity 3 mg/0.5 mL pens. The Firm Fixed Price Delivery Order is valued at $10,026.35 and has an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,322.24 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJGG3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $10,770.28, is a Firm Fixed Price Delivery Order for the supply of the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5 ml. The ultimate completion date for this contract is January 12, 2024.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation, indicating open competition. The award demonstrates Amerisourcebergen's capability to meet the diverse and critical pharmaceutical needs of the federal government, particularly the military and veteran healthcare systems.

Generated 5/13/25, 10:04 AM